Fabrinet's stock has surged 250.64% over the past year, fueled by accelerating revenue growth of 35.9% and a new high-performance computing partnership with Amazon Web Services. Despite a high trailing P/E of 53x, the forward P/E of 13x reflects strong earnings growth, supported by durable data center demand and emerging optics programs. Risks include negative free cash flow, rising liabilities, and insider selling, but these are linked to capacity investments rather than weakening fundamentals. Investors should watch the upcoming May 6 earnings report for further growth confirmation.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
